Teno J M, Fisher E, Hamel M B, Wu A W, Murphy D J, Wenger N S, Lynn J, Harrell F E
Center For Gerontology and Health Care Research, Brown University, Providence, Rhode Island 02912, USA.
J Am Geriatr Soc. 2000 May;48(S1):S70-4. doi: 10.1111/j.1532-5415.2000.tb03144.x.
Despite concern about the high costs and the uncertain benefit of prolonged treatment in the intensive care unit (ICU), there has been little research examining decision-making and outcomes for patients with prolonged ICU stays.
To evaluate decision-making and outcomes for seriously ill patients with an ICU stay of at least 14 days.
A prospective cohort study.
Five teaching hospitals.
Seriously ill patients enrolled in the Study To Understand Prognoses and Preferences for Risks and Outcomes of Treatments (SUPPORT).
Patients, their surrogate decision-makers, and their physicians were interviewed about prognosis, communication, and goals of medical care. Based on age, diagnoses, comorbid illnesses, and acute physiology data, the SUPPORT Prognostic Model provided estimates of 6-month survival on study days 1, 3, 7, and 14. Hospital costs were estimated from hospital billing data.
Of the 9105 patients enrolled in SUPPORT, 1494 (16%) had ICU stays of 14 days or longer. The median length of stay in an ICU was 4 days for the entire SUPPORT cohort and 35 days for patients who were treated in an ICU for 14 days or longer. Median hospital costs were $76,501 for patients who had ICU stays 14 days or longer and $10,916 for patients who did not have long ICU stays. Fifty-five percent of patients with long ICU stays had died by 6 months, and an additional 19% had substantial functional impairment. Among patients with ICU stays of at least 14 days, only 20% had estimates of 6-month survival that fell below 10% at any time during their hospitalization. For patients with long ICU stays, the mean predicted probability of 6-month survival was 0.46 on study Day 3 and 0.47 on study Day 14. Fewer than 40% of patients (or their surrogates) reported that their physicians had talked with them about their prognoses or preferences for life-sustaining treatment. Among the patients who preferred a palliative approach to care, only 29% thought that their care was consistent with that aim. Those who discussed their preferences for care with a physician were 1.9 times more likely to believe that treatment was in accord with their preferences for palliation (95% CI, 1.4-2.5)
Prolonged ICU stays were expensive and were often followed by death or disability. Patients reported low rates of discussions with their physicians about their prognoses and preferences for life-sustaining treatments. Many preferred that care focus on palliation and believed that care was inconsistent with their preferences. Patients were more likely to receive care consistent with their preferences if they had discussed their care preferences with their physicians.
尽管人们担心重症监护病房(ICU)长期治疗费用高昂且益处不明,但针对ICU长期住院患者的决策制定和治疗结果的研究却很少。
评估在ICU住院至少14天的重症患者的决策制定和治疗结果。
一项前瞻性队列研究。
五家教学医院。
参与“了解治疗风险和结果的预后及偏好研究”(SUPPORT)的重症患者。
就预后、沟通和医疗护理目标对患者、其替代决策者及其医生进行了访谈。根据年龄、诊断、合并症和急性生理学数据,SUPPORT预后模型提供了研究第1、3、7和14天6个月生存率的估计值。根据医院计费数据估算住院费用。
在参与SUPPORT的9105名患者中,1494名(16%)在ICU住院14天或更长时间。整个SUPPORT队列在ICU的中位住院时间为4天,而在ICU接受治疗14天或更长时间的患者为35天。ICU住院14天或更长时间的患者中位住院费用为76,501美元,未在ICU长期住院的患者为10,916美元。在ICU长期住院的患者中,55%在6个月时死亡,另有19%有严重功能障碍。在ICU住院至少14天的患者中,只有20%在住院期间任何时候的6个月生存率估计低于10%。对于ICU长期住院患者,研究第3天6个月生存的平均预测概率为0.46,研究第14天为0.47。不到40%的患者(或其替代者)报告称他们的医生与他们讨论过预后或维持生命治疗的偏好。在倾向于姑息治疗方式 的患者中,只有29%认为他们的治疗符合该目标。那些与医生讨论过护理偏好的患者认为治疗符合其姑息治疗偏好的可能性高1.9倍(95%CI,1.4 - 2.5)
ICU长期住院费用高昂,且常常导致死亡或残疾。患者报告称与医生讨论预后和维持生命治疗偏好的比例较低。许多患者倾向于护理以姑息治疗为重点,并认为护理与他们的偏好不一致。如果患者与医生讨论过护理偏好,他们更有可能接受符合其偏好 的护理。